These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 9037435)

  • 1. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The opioid tramadol demonstrates excitatory properties of non-opioid character--a preclinical study using alfentanil as a comparison].
    Freye E; Latasch L; Von Bredow G; Neruda B
    Schmerz; 1998 Feb; 12(1):19-24. PubMed ID: 12799988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
    Freye E; Levy JV
    Eur J Anaesthesiol; 2010 Feb; 27(2):174-80. PubMed ID: 20077594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of S-(+)-ketamine with opiate receptors. Effects on EEG, evoked potentials and respiration in awake dogs].
    Freye E; Latasch L; Schmidhammer H; Portoghese P
    Anaesthesist; 1994 Nov; 43 Suppl 2():S52-8. PubMed ID: 7840415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids with different affinity for subreceptors induce different effects on early and late sensory evoked potentials (SEP) in man.
    Freye E; Buhl R; Ciaramelli F
    NIDA Res Monogr; 1986; 75():551-4. PubMed ID: 2829001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dog.
    Freye E; Buhl R; Schenk GK
    Funct Neurol; 1987; 2(3):281-92. PubMed ID: 2826307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical pharmacology of short-acting mu opioids in drug abusers.
    Greenwald MK; June HL; Stitzer ML; Marco AP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1228-36. PubMed ID: 8667183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatosensory evoked potentials under alfentanyl].
    Freye E; Segeth M; Hartung E
    Anaesthesist; 1984 Feb; 33(2):103-7. PubMed ID: 6143516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of nicotinic and opioid processes in the medulla oblongata and nucleus ambiguus of the dog.
    Wu KM; Martin WR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):302-7. PubMed ID: 6313895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
    Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
    Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
    Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of alfentanil and fentanyl in short operations with special reference to their duration of action and postoperative respiratory depression.
    van Leeuwen L; Deen L; Helmers JH
    Anaesthesist; 1981 Aug; 30(8):397-9. PubMed ID: 6116461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of morphine, meperidine, fentanyl, and sufentanil in balanced anesthesia: a double-blind study.
    Flacke JW; Bloor BC; Kripke BJ; Flacke WE; Warneck CM; Van Etten AP; Wong DH; Katz RL
    Anesth Analg; 1985 Sep; 64(9):897-910. PubMed ID: 2862810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine.
    Sarton E; Teppema L; Dahan A
    Adv Exp Med Biol; 2008; 605():486-91. PubMed ID: 18085322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.
    Cox EH; Kerbusch T; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1095-103. PubMed ID: 9495871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.